Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Animal Health, Inc. (now Jaguar Health, Inc.) on December 18, 2015, covering events that occurred on December 15, 2015. The filing addresses significant changes in the company's executive leadership.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and compensatory arrangements rather than financial performance.
Material Changes
- Resignation: John A. Kallassy resigned as Chief Financial Officer, effective December 15, 2015.
- Appointment: Karen Wright was appointed as the new Chief Financial Officer, effective December 15, 2015.
- Compensation Package: Ms. Wright's annual base salary is set at $240,000 with an annual target bonus of 25% of base salary.
- Equity Grant: Subject to Board and stockholder approval, Ms. Wright is eligible for options to purchase 20,000 shares of common stock. Vesting begins 25% nine months after the start date, followed by monthly vesting over 27 months.
Outlook, Risks, and Unusual Items
The filing includes a change-in-control provision for Ms. Wright's equity awards. In the event of a change in control, vesting will accelerate if her position is eliminated or if she is not offered substantially similar employment terms. No other risks, contingencies, or unusual items were disclosed in this specific filing.
Investor Verification Checklist
- Verify the approval status of the 20,000 stock option grant for Karen Wright by the Board and stockholders.
- Review the full text of the Offer Letter (Exhibit 10.1) for complete terms and conditions.
- Confirm the transition timeline and handover process between the outgoing and incoming CFOs.
- Check subsequent filings for any updates on the company's financial status following this leadership change.